COM:MARKSANSPHARMA
Marksans Pharma
- Stock
Last Close
308.09
25/09 10:00
Market Cap
87.17B
Beta: -
Volume Today
3.75M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 901.40M - | 1.16B 29.07% | 1.49B 28.02% | 1.79B 20.13% | 2.04B 14.06% | 2.56B 25.27% | 2.68B 4.64% | 3.23B 20.76% | 4.14B 28.26% | 4.55B 9.70% | |
average payables | 696.22M - | 951.01M 36.60% | 1.13B 18.82% | 1.40B 24.23% | 1.15B 18.34% | 867.75M 24.30% | 1.05B 21.33% | 1.37B 29.73% | 1.84B 34.99% | 2.15B 16.80% | |
average receivables | 921.99M - | 2.14B 132.30% | 2.60B 21.55% | 3.44B 32.19% | 4.15B 20.64% | ||||||
book value per share | 3.69 - | 9.28 151.43% | 11.10 19.63% | 10.86 2.14% | 11.50 5.91% | 13.25 15.21% | 15.54 17.24% | 21.66 39.38% | 29.37 35.62% | 42.16 43.54% | |
capex per share | -0.89 - | -3.22 261.64% | -0.68 78.96% | -0.95 40.31% | -0.32 66.23% | -1.46 353.55% | -1.13 22.14% | -1.13 0.20% | -1.30 14.47% | ||
capex to depreciation | -2.26 - | -4.69 107.44% | -0.92 80.33% | -1.45 57.33% | -0.58 60.26% | -2.24 287.93% | -1.28 42.58% | -1.03 19.43% | -1.03 0.04% | ||
capex to operating cash flow | -0.24 - | -4.28 1,714.21% | -3.14 26.71% | -0.66 78.94% | -0.48 27.38% | -0.28 40.82% | -0.26 8.55% | -0.47 79.71% | -0.23 51.60% | ||
capex to revenue | -0.05 - | -0.15 222.52% | -0.04 75.50% | -0.04 17.94% | -0.01 68.79% | -0.05 296.52% | -0.03 35.74% | -0.03 7.74% | -0.03 7.49% | ||
cash per share | 1.22 - | 4.53 271.48% | 0.86 80.95% | 0.61 28.72% | 0.97 57.84% | 0.80 17.28% | 2.28 183.43% | 5.16 126.70% | 8.47 64.23% | 17.37 105.12% | |
days of inventory on hand | 101.77 - | 106.61 4.76% | 120.16 12.71% | 146.99 22.33% | 145.23 1.19% | 206.83 42.41% | 155.32 24.91% | 238.57 53.60% | 207.11 13.19% | 192.03 7.28% | |
days payables outstanding | 82.52 - | 87.69 6.27% | 85.20 2.84% | 125.10 46.83% | 44.93 64.09% | 74.81 66.51% | 67.11 10.29% | 99.52 48.29% | 97.63 1.90% | 91.35 6.43% | |
days sales outstanding | 68.17 - | 78.85 15.66% | 73.81 6.38% | 101.49 37.50% | 82.53 18.69% | ||||||
debt to assets | 0.26 - | 0.12 52.44% | 0.12 0.72% | 0.15 19.02% | 0.16 10.93% | 0.12 22.93% | 0.03 73.49% | 0.03 16.02% | 0.07 143.27% | 0.06 16.90% | |
debt to equity | 0.88 - | 0.22 75.45% | 0.19 10.01% | 0.25 26.71% | 0.25 1.52% | 0.18 26.26% | 0.05 74.77% | 0.04 17.48% | 0.09 139.52% | 0.07 23.54% | |
dividend yield | 0.01 - | 0.00 75.69% | 0.01 244.43% | 0.01 20.56% | 0.00 76.35% | 0.00 135.00% | 0.05 1,139.38% | 0.00 96.14% | 0.01 183.84% | 0.00 38.58% | |
earnings yield | 0.08 - | 0.04 44.70% | 0.04 4.05% | 0.00 88.09% | 0.02 382.73% | 0.08 218.06% | 0.21 180.26% | 0.12 45.03% | 0.10 14.02% | 0.09 9.23% | |
enterprise value | 9.99B - | 24.31B 143.23% | 19.48B 19.84% | 20.14B 3.40% | 14.62B 27.44% | 11.30B 22.73% | 5.05B 55.25% | 18.69B 269.80% | 16.27B 12.96% | 26.54B 63.16% | |
enterprise value over ebitda | 8.48 - | 13.45 58.56% | 13.79 2.55% | 40.65 194.72% | 17.58 56.74% | 8.50 51.63% | 2.68 68.52% | 5.27 97.03% | 5.52 4.72% | 6.66 20.57% | |
ev to operating cash flow | 15.41 - | 15.73 2.07% | 63.26 302.12% | 227.82 260.15% | 24.81 89.11% | 41.23 66.20% | 2.41 94.16% | 10.46 334.35% | 16.39 56.73% | 11.18 31.78% | |
ev to sales | 1.59 - | 3.05 92.34% | 2.18 28.51% | 2.63 20.40% | 1.60 39.01% | 1.14 28.57% | 0.45 60.88% | 1.37 205.20% | 1.10 19.54% | 1.43 30.39% | |
free cash flow per share | 1.68 - | 2.88 71.38% | -2.47 185.62% | -0.46 81.29% | 0.49 205.71% | 0.35 28.70% | 3.67 954.97% | 3.23 11.97% | 1.29 60.00% | 4.44 243.37% | |
free cash flow yield | 0.07 - | 0.05 33.83% | -0.05 214.47% | -0.01 81.63% | 0.01 247.46% | 0.01 7.14% | 0.26 1,869.52% | 0.06 75.50% | 0.03 56.09% | 0.06 121.92% | |
graham net net | -6.31 - | -0.91 85.52% | -3.43 275.24% | -4.43 29.23% | -2.44 44.85% | 1.63 166.80% | 3.65 123.60% | 7.28 99.54% | 11.01 51.21% | 20.54 86.66% | |
graham number | 12.45 - | 23.62 89.76% | 21.89 7.34% | 7.54 65.56% | 14.43 91.44% | 24.21 67.73% | 32.12 32.67% | 53.29 65.94% | 54.92 3.06% | 77.98 41.98% | |
income quality | 0.90 - | 1.41 56.64% | 0.29 79.59% | 0.57 97.53% | 1.18 107.79% | 0.26 77.80% | 1.34 408.59% | 0.59 55.72% | 0.40 32.21% | 0.70 75.33% | |
intangibles to total assets | 0.15 - | 0.09 37.01% | 0.15 55.39% | 0.14 6.78% | 0.13 6.36% | 0.09 30.12% | 0.09 3.37% | 0.05 40.78% | 0.05 1.01% | 0.05 7.63% | |
interest coverage | 17.92 - | 16.98 5.28% | 3.92 76.91% | 7.95 102.68% | 18.45 132.24% | 32.63 76.81% | 91.78 181.29% | 46.34 49.50% | 37.99 18.02% | ||
interest debt per share | 3.25 - | 2.22 31.75% | 2.32 4.28% | 2.78 19.94% | 3.04 9.49% | 2.59 14.72% | 0.85 67.38% | 0.92 8.52% | 2.84 209.20% | 3.19 12.43% | |
inventory turnover | 3.59 - | 3.42 4.54% | 3.04 11.27% | 2.48 18.25% | 2.51 1.21% | 1.76 29.78% | 2.35 33.17% | 1.53 34.90% | 1.76 15.19% | 1.90 7.85% | |
invested capital | 0.88 - | 0.22 75.45% | 0.19 10.01% | 0.25 26.71% | 0.25 1.52% | 0.18 26.26% | 0.05 74.77% | 0.04 17.48% | 0.09 139.52% | 0.07 23.54% | |
market cap | 9.21B - | 25.34B 175.13% | 18.95B 25.20% | 19.30B 1.84% | 13.83B 28.31% | 10.62B 23.22% | 5.69B 46.44% | 20.45B 259.35% | 18.62B 8.91% | 29.14B 56.47% | |
net current asset value | 16.68M - | 2.21B 13,159.41% | 1.81B 18.28% | 1.82B 0.91% | 2.00B 9.79% | 2.80B 40.06% | 3.42B 22.12% | 5.79B 69.17% | 7.84B 35.34% | 12.50B 59.42% | |
net debt to ebitda | 0.67 - | -0.57 185.70% | 0.38 166.00% | 1.71 353.17% | 0.94 44.83% | 0.51 46.11% | -0.34 166.27% | -0.49 47.13% | -0.80 61.64% | -0.65 18.57% | |
net income per share | 1.87 - | 2.67 43.21% | 1.92 28.23% | 0.23 87.88% | 0.80 246.05% | 1.97 144.19% | 2.95 50.12% | 5.83 97.55% | 4.56 21.68% | 6.41 40.44% | |
operating cash flow per share | 1.68 - | 3.77 124.33% | 0.75 80.07% | 0.22 71.29% | 1.44 566.34% | 0.67 53.50% | 5.13 666.36% | 4.37 14.86% | 2.42 44.47% | 5.74 136.53% | |
payables turnover | 4.42 - | 4.16 5.90% | 4.28 2.92% | 2.92 31.89% | 8.12 178.44% | 4.88 39.94% | 5.44 11.47% | 3.67 32.56% | 3.74 1.93% | 4.00 6.87% | |
receivables turnover | 5.35 - | 4.63 13.54% | 4.94 6.82% | 3.60 27.27% | 4.42 22.98% | ||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.17 - | 0.18 3.64% | 0.13 28.76% | 0.01 88.50% | 0.05 253.48% | 0.11 112.19% | 0.15 34.98% | 0.21 38.51% | 0.12 41.38% | 0.13 5.88% | |
revenue per share | 16.35 - | 19.46 19.04% | 21.82 12.13% | 18.74 14.12% | 22.30 18.97% | 24.12 8.18% | 27.59 14.38% | 33.43 21.17% | 36.16 8.17% | 44.75 23.74% | |
roe | 0.51 - | 0.29 43.04% | 0.17 40.01% | 0.02 87.61% | 0.07 226.74% | 0.15 111.96% | 0.19 28.04% | 0.27 41.73% | 0.16 42.25% | 0.15 2.16% | |
roic | 0.28 - | 0.24 11.93% | 0.15 37.11% | 0.02 85.78% | 0.06 190.65% | 0.13 108.24% | 0.18 40.40% | 0.27 45.74% | 0.14 49.20% | 0.14 2.50% | |
sales general and administrative to revenue | 0.02 - | 0.03 4.23% | 0.02 9.70% | 0.02 3.98% | 0.02 32.31% | 0.02 9.71% | 0.02 4.00% | ||||
shareholders equity per share | 3.69 - | 9.28 151.43% | 11.10 19.63% | 10.86 2.14% | 11.50 5.91% | 13.25 15.21% | 15.54 17.24% | 21.66 39.38% | 29.37 35.62% | 42.16 43.54% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 756.51M - | 3.24B 328.73% | 3.57B 10.12% | 3.48B 2.47% | 3.87B 11.21% | 4.81B 24.17% | 5.66B 17.76% | 8.38B 47.99% | 11.34B 35.31% | 16.56B 45.96% | |
tangible book value per share | 3.86 - | 9.48 145.34% | 11.30 19.29% | 11.01 2.56% | 9.46 14.07% | 11.75 24.17% | 13.84 17.76% | 20.48 47.99% | 27.71 35.31% | 40.00 44.34% | |
working capital | 238.26M - | 2.23B 834.27% | 1.81B 18.82% | 1.82B 0.91% | 2.16B 18.37% | 2.99B 38.43% | 3.71B 23.99% | 6.04B 62.98% | 8.45B 39.93% | 13.34B 57.91% |
All numbers in (except ratios and percentages)